R&D Pipeline
- Prototype Design: Development and validation of an exteroceptive prototype for evaluation of cognitive deficits in Alzheimer’s disease using preclinical study design. At present, we aim to develop a prototype that could evaluate different domains of memory at one place in pre-clinical setting.
Affordable Point-of-Care Diagnostics: We aim to develop an affordable point-of-care diagnostics. Our R&D pipeline focus on developing rapid, portable, low-cost diagnostic devices for resource-limited healthcare settings, rural clinics, and primary healthcare facilities. At present we are developing Proof-of-Concept: Paper-based colorimetric diagnostic, Rapid lateral-flow assay, Portable anemia screening device
- Research on nutraceuticals and natural products has gained considerable attention for their potential neuroprotective, antioxidant, anti-inflammatory, and metabolic regulatory effects. In ischemic stroke, plant-derived bioactive compounds (e.g., polyphenols, flavonoids) are being investigated for reducing oxidative stress, neuroinflammation, and neuronal injury. In Alzheimer’s disease, phytochemicals are studied for their potential effects on amyloid-β accumulation, tau pathology, and cognitive decline. In Parkinson’s disease, natural antioxidants and polyphenols are explored for dopaminergic neuroprotection and mitochondrial protection. In diabetes, nutraceuticals and dietary polyphenols are investigated for improving glucose metabolism and insulin sensitivity.
- JOURNALRISE - The Journal Excellence & Standards Advancement Program
One Platform. Higher Standards. Stronger Research.
Core pillars
- Editorial and peer-review excellence
- Research integrity and publication ethics
- Journal indexing and discoverability readiness
- Manuscript quality and reporting standards
- Digital publishing and editorial workflow improvement
- Continuous quality assessment and benchmarking
- INTEGRATED WOUND MONITOR AND DRUG RELEASE PATCH
